2007-04-19T00:00:00
Cancer Research UK has highlighted a study published in the Lancet that has found women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud